NO20021254L - Signalsekvenser for fremstilling av LEU-hirudin via sekresjon fra E. Coli i et dyrkningsmedium - Google Patents

Signalsekvenser for fremstilling av LEU-hirudin via sekresjon fra E. Coli i et dyrkningsmedium

Info

Publication number
NO20021254L
NO20021254L NO20021254A NO20021254A NO20021254L NO 20021254 L NO20021254 L NO 20021254L NO 20021254 A NO20021254 A NO 20021254A NO 20021254 A NO20021254 A NO 20021254A NO 20021254 L NO20021254 L NO 20021254L
Authority
NO
Norway
Prior art keywords
hirudin
leu
coli
preparation
culture medium
Prior art date
Application number
NO20021254A
Other languages
English (en)
Other versions
NO329723B1 (no
NO20021254D0 (no
Inventor
Paul Habermann
Rudolf Bender
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20021254D0 publication Critical patent/NO20021254D0/no
Publication of NO20021254L publication Critical patent/NO20021254L/no
Publication of NO329723B1 publication Critical patent/NO329723B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20021254A 1999-09-18 2002-03-13 Signalsekvenser for fremstilling av LEU-hirudin via sekresjon og anvendelsen av denne NO329723B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944870A DE19944870A1 (de) 1999-09-18 1999-09-18 Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
PCT/EP2000/008537 WO2001021662A1 (de) 1999-09-18 2000-09-01 Signalsequenzen zur herstellung von leu-hirudin über sekretion durch e. coli in das kulturmedium

Publications (3)

Publication Number Publication Date
NO20021254D0 NO20021254D0 (no) 2002-03-13
NO20021254L true NO20021254L (no) 2002-05-07
NO329723B1 NO329723B1 (no) 2010-12-06

Family

ID=7922547

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021254A NO329723B1 (no) 1999-09-18 2002-03-13 Signalsekvenser for fremstilling av LEU-hirudin via sekresjon og anvendelsen av denne

Country Status (28)

Country Link
US (1) US7455987B1 (no)
EP (1) EP1216259B1 (no)
JP (1) JP4669181B2 (no)
KR (1) KR100737189B1 (no)
CN (2) CN1192037C (no)
AR (1) AR025660A1 (no)
AT (1) ATE357458T1 (no)
AU (1) AU775923B2 (no)
BR (1) BR0014519A (no)
CA (1) CA2385287C (no)
CZ (1) CZ2002899A3 (no)
DE (2) DE19944870A1 (no)
DK (1) DK1216259T3 (no)
EE (1) EE05187B1 (no)
HR (1) HRP20020226B1 (no)
HU (1) HUP0202596A3 (no)
IL (2) IL148624A0 (no)
ME (1) MEP27908A (no)
MX (1) MXPA02002469A (no)
NO (1) NO329723B1 (no)
NZ (1) NZ517825A (no)
PL (1) PL205117B1 (no)
RS (1) RS50435B (no)
RU (1) RU2261867C2 (no)
SK (1) SK287865B6 (no)
TR (2) TR200200667T2 (no)
WO (1) WO2001021662A1 (no)
ZA (1) ZA200202106B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
CA2546157C (en) * 2003-11-21 2014-07-22 Dow Global Technolgies Inc. Improved expression systems with sec-system secretion
BRPI0513826A2 (pt) 2004-07-26 2010-06-22 Dow Global Technologies Inc processo para expressão de proteìna melhorada através de engenharia de cepa
DE102005046113A1 (de) * 2005-09-27 2007-03-29 Sanofi-Aventis Deutschland Gmbh Verfahren zur Amidierung von Polypetiden mit C-terminalen basischen Aminosäuren unter Verwendung spezifischer Endoproteasen
DE102006044841A1 (de) * 2006-09-22 2008-04-03 Wacker Chemie Ag Signalpeptid zur Produktion von rekombinanten Proteinen
EP2468869B1 (en) 2007-01-31 2015-03-18 Pfenex Inc. Bacterial leader sequences for increased expression
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
PL2968470T3 (pl) 2013-03-12 2021-05-31 The General Hospital Corporation Zmodyfikowane białka stanowiące substancję hamującą rozwój przewodów müllera (mis) i ich zastosowania do leczenia chorób
ES2912283T3 (es) 2013-12-11 2022-05-25 Massachusetts Gen Hospital Uso de proteínas de tipo sustancia inhibidora mülleriana (SIM) para la anticoncepción y conservación de la reserva ovárica
CN108220369B (zh) * 2017-12-04 2021-03-12 广东双骏生物科技有限公司 一种生产重组水蛭素的方法
CN108359689B (zh) * 2018-01-19 2021-03-23 华中农业大学 利用抗病基因识别无毒效应蛋白以鉴定具有分泌功能信号肽的方法
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
IL88925A (en) * 1985-04-11 1995-11-27 Hoechst Ag Hirudin derivative and pharmaceutical composition containing same
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
ES2093717T3 (es) * 1990-11-08 1997-01-01 Japan Energy Corp Mutante de hirudina, su produccion, anticoagulante, vector secretor, microorganismo transformado por el indicado vector y produccion de un producto a partir de dicho microorganismo.
JPH07119237B2 (ja) * 1990-11-08 1995-12-20 株式会社ジャパンエナジー ヒルジン変異体，その製造法及び抗凝血剤
PT100580A (pt) * 1991-06-12 1993-09-30 Regeneron Pharma Producao e recuperacao de neurotrofinas recombinantes
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
DE4140381A1 (de) 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet

Also Published As

Publication number Publication date
IL148624A0 (en) 2002-09-12
JP2003510041A (ja) 2003-03-18
EP1216259A1 (de) 2002-06-26
MXPA02002469A (es) 2002-08-28
NO329723B1 (no) 2010-12-06
US7455987B1 (en) 2008-11-25
BR0014519A (pt) 2002-06-11
NO20021254D0 (no) 2002-03-13
HK1068352A1 (en) 2005-04-29
DE50014189D1 (de) 2007-05-03
EP1216259B1 (de) 2007-03-21
AR025660A1 (es) 2002-12-11
AU775923B2 (en) 2004-08-19
NZ517825A (en) 2004-07-30
ZA200202106B (en) 2003-01-09
HRP20020226B1 (hr) 2010-08-31
IL148624A (en) 2009-08-03
RU2002110278A (ru) 2004-03-27
DE19944870A1 (de) 2001-03-29
DK1216259T3 (da) 2007-07-02
HK1049172A1 (en) 2003-05-02
PL205117B1 (pl) 2010-03-31
CN1192037C (zh) 2005-03-09
HUP0202596A3 (en) 2005-01-28
TR200501541T2 (tr) 2005-06-21
EE05187B1 (et) 2009-06-15
JP4669181B2 (ja) 2011-04-13
MEP27908A (en) 2010-10-10
CN1550502A (zh) 2004-12-01
SK3622002A3 (en) 2003-06-03
RU2261867C2 (ru) 2005-10-10
SK287865B6 (sk) 2012-02-03
YU14602A (sh) 2005-07-19
PL354444A1 (en) 2004-01-12
CA2385287A1 (en) 2001-03-29
RS50435B (sr) 2009-12-31
HRP20020226A2 (en) 2004-04-30
CA2385287C (en) 2010-10-19
CZ2002899A3 (cs) 2002-06-12
WO2001021662A1 (de) 2001-03-29
KR20020034188A (ko) 2002-05-08
CN1374970A (zh) 2002-10-16
KR100737189B1 (ko) 2007-07-10
EE200200139A (et) 2003-06-16
AU6842100A (en) 2001-04-24
CN1269838C (zh) 2006-08-16
TR200200667T2 (tr) 2002-06-21
ATE357458T1 (de) 2007-04-15
HUP0202596A2 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
NO20021254L (no) Signalsekvenser for fremstilling av LEU-hirudin via sekresjon fra E. Coli i et dyrkningsmedium
NO20023123D0 (no) Fremgangsmåter for pulmonal avlevering av interleukin-2
ITTO20000303A0 (it) Procedimento per l'animazione di un modello sintetizzato di volto umano pilotata da un segnale audio.
IL134026A (en) Circuitry for signal measurement
AU2001290075A1 (en) Novel alkanoic acid derivatives
DK0821693T3 (da) Nye DNA-sekvenser fra human cytomegalovirus (HCMV)
FI915089L (fi) Nya muramyldipeptidderivat och influenssavaccin innehaollande dessa derivat.
DE60012713D1 (de) Durch xanthurensäure modifizierte proteine
EP1158996A4 (en) NEW AMIDE SECRETAGOGUES OF GROWTH HORMONE DERIVATIVES
AU2001249074A1 (en) Human hepatocyte growth factor activator inhibitor homologue
ATE203665T1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
ZA200006419B (en) Use of APO B Secretion/MTP Inhibitors.
AU5649599A (en) Tongue cleaner
NO20021727L (no) Fremgangsmåte for fremstilling av 3,4-metylen-dioksy- mandelisk syre
ZA200006417B (en) Use of Apo B secretion/MTP inhibitors.
AU1362101A (en) Novel traf family proteins
DE10082298D2 (de) Chimäre Proteine
AP2004003005A0 (en) Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives.
AU2001242738A1 (en) Novel artificial organ system
AU1535301A (en) Genetic indicators of tobacco consumption
DE69933363D1 (de) Modulare RF-IC-Architektur
GB9902858D0 (en) Billiard cues
GB9919086D0 (en) Composition cue butt
AU2001233501A1 (en) Purification of vascular endothelial growth factor-b
ATA78199A (de) Kanüle zur gewebeabsaugung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees